Have a personal or library account? Click to login
Hyperbaric Oxygen Therapy (HBOT) as a Therapeutic Option for Patients with Atopic Dermatitis (AD) – Own Experiences and Literature Review Cover

Hyperbaric Oxygen Therapy (HBOT) as a Therapeutic Option for Patients with Atopic Dermatitis (AD) – Own Experiences and Literature Review

Open Access
|Nov 2017

References

  1. 1. Mathieu D, Marroni A, Kot J (2017) Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and nonaccepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med, 47(1): 24-32. PMID: 28357821;10.28920/dhm47.2.131-132614775528641327
  2. 2. Thom SR (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg, 127 (Suppl 1): 131S-141S. DOI:10.1097/PRS.0b013e3181fbe2bf;10.1097/PRS.0b013e3181fbe2bf305832721200283
  3. 3. Kierznikowicz B, Ulewicz K (1976) Influence of oxygen hyperbaria on the activity of complement in human’s sera. Acta Physiol Pol, 27: 409-411. PMID: 983722;
  4. 4. Hansbrough JF, Piacentine JG, Eiseman B (1980) Immunosuppression by hyperbaric oxygen. Surgery, 87: 662-667. PMID: 7376077;
  5. 5. Ulewicz K, Zannini D (1986) On the possibility of hyperbaric oxygen therapy in some pathological reactions of immunological hypersensitivity. Bull Inst Mar Trop Med Gdynia, 37 (1-2): 71-79. PMID: 3555661;
  6. 6. Saito K, Tanaka Y, Ota T, Eto S, Yamashita U (1991) Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin Exp Immunol, 86: 322-327. DOI: 10.1111/j.1365-2249.1991.tb05817.x;10.1111/j.1365-2249.1991.tb05817.x15541111934599
  7. 7. Olszański R, Pachut M, Sićko Z, Sztaba-Kania M, Wilkowska A (1992) Efficacy of hyperbaric oxygenation in atopic dermatitis. Bull Inst Mar Trop Med Gdynia, 43 (1-4): 79-82. PMID: 1345603;
  8. 8. Di Cesare A, Di Meglio P, Nestle FO (2008) A role for Th17 cells in the immunopathogenesis of atopic dermatitis ? J Invest Dermatol, 128: 2569-2571. DOI: 10.1038/jid.2008.283;
  9. 9. Kudchodkar BJ, Jones H, Simecka J, Dory L (2008) Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol, 128(3): 435-441. DOI:10.1016/j.clim.2008.05.004;10.1016/j.clim.2008.05.004256253318595776
  10. 10. Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R (2009) The protective role of ROS in autoimmune disease. Trends Immunol, 30: 201-208. DOI:10.1016/j.it.2009.03.004;
  11. 11. Kim HR, Kim JH, Choi EJ, Lee YK, Kie JH, Jang MH, Seoh JY (2014) Hyperoxygenation attenuated a murine model of Atopic Dermatitis through raising skin level of ROS. PLoS ONE, 9 (10): e109297. DOI: 10.1371/journal.pone.0109297;
  12. 12. Berke R, Singh A, Guralnick M (2012) Atopic dermatitis: an overview. Am Fam Physician, 86: 35-42. PMID: 22962911;
  13. 13. Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W, Kaczmarski M, Kowalewski C, Kruszewski J, Maj J, Silny W, Śpiewak R, Petranyuk A (2015) Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postep Derm Alergol, 32 (4): 239-249. DOI: 10.5114/pdia.2015.53319;10.5114/pdia.2015.53319456583826366146
  14. 14. Won HY, Sohn JH, Min HJ, Lee K, Woo HA, Ho YS, Park JW, Rhee SG, Hwang ES (2010) Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid Redox Signal, 13: 575-587. DOI: 10.1089/ars.2009.2989;10.1089/ars.2009.298920367278
  15. 15. Erdmann D, Roth AC, Hussmann J, Lyons SF, Mody NJ, Kucan JO, Russell RC (1995) Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. Undersea Hyperb Med 22: 395-399. PMID: 8574127;
  16. 16. Kudchodkar BJ, Wilson J, Lacko A, Dory L (2000) Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol, 20: 1637-1643. DOI: 10.1161/01.ATV.20.6.1637;10.1161/01.ATV.20.6.163710845883
  17. 17. Akin ML, Gulluoglu BM, Uluutku H, Erenoglu C, Elbuken E, Yildirim S, Celenk T (2002) Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med, 29: 279-285. PMID: 12797669;
  18. 18. Benson RM, Minter LM, Osborne BA (2003) Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human bloodderived monocyte-macrophages. Clin Exp Immunol, 134: 57-62. DOI: 10.1046/j.1365-2249.2003.02248.x;10.1046/j.1365-2249.2003.02248.x180884312974755
  19. 19. Butler G, Michaels JC, Al-Waili N, Finkelstein M, Allen M, Petrillo R, Carrey Z, Kolanuvada B, Lee BY, Riera AG, Michaels CC, Urteaga G (2009) Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature. J Med Case Rep, 3: 7023. DOI: 10.4076/1752-1947-3-702310.4076/1752-1947-3-7023
  20. 20. Olivieri AN, Mellos A, Duilio C, Di Meglio M, Mauro A, Perrone L (2010) Refractory vasculitic ulcer of the toe in adolescent suffering fromSystemic Lupus Erythematosus treated successfully with hyperbaric oxygen therapy. Ital J Pediatr, 36: 72. DOI:10.1186/1824-7288-36-72; 10.1186/1824-7288-36-72298880721040521
  21. 21. Faleo G, Fotino C, Bocca N, Molano RD, Zahr-Akrawi E, Molina J, Villate S, Umland O, Skyler JS, Bayer AL, Ricordi C, Pileggi A (2012)Prevention of autoimmune diabetes and induction of beta-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes, 61: 1769-1778. DOI: 10.2337/db11-0516; 10.2337/db11-0516
  22. 22. Jacob BB, Thuning CA, Sacksteder MR, Warren JM (1979) Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen. Transplantation 28: 70-72. PMID: 377598;10.1097/00007890-197907000-00017
  23. 23. Granowitz EV, Skulsky EJ, Benson RM, Wright J, Garb JL, Cohen ER, Smithline EC, Brown RB (2002) Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med, 29: 216-225. PMID: 12670123;
  24. 24. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z (2006) Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab, 26: 666-674. DOI: 10.1038/sj.jcbfm.9600221;10.1038/sj.jcbfm.9600221
  25. 25. Zhang J, Fife CE, Currie MS, Moon RE, Piantadosi CA, Vann RD (1991) Venous gas emboli and complement activation after deep repetitive air diving. Undersea Biomed Res, 18 (4): 293-302. PMID: 1887517;
  26. 26. Pekna M, Ersson A (1996) Complement system response to decompression. Undersea Hyperb Med, 23 (1): 31-34. PMID: 8653063;
  27. 27. Konarski M, Olszański R, Baj Z, Buczyński A, Kłos R, Skrzyński S (2000) [Influence of air hyperbaric exposures on selected haematological parameters and complement system] [Article in Polish]. Pol Przegl Med Lot, 6 (1): 25-31. ISSN 1233-0779;
  28. 28. Olszański R, Konarski M, Kierznikowicz B (2002) Changes of selected morphotic parameters and blood plasma proteins in blood of divers after a single short-time operational heliox exposure. Int Marit Health, 53 (1-4): 111-121. PMID: 12608594;
  29. 29. Kłos R, Konarski M, Olszański R (2004) The implementation of factor analysis for the evaluation of selected blood parameter changes induced by hyperbaric exposure. Int Marit Health, 55 (1-4): 87-102. PMID: 15881546;
  30. 30. Nyquist P, Ball R, Sheridan MJ (2007) Complement levels before and after dives with a high risk of DCS. Undersea Hyperb Med, 34 (3): 191-197. PMID: 17672175;
  31. 31. Warren J, Sacksteder MR, Thuning CA (1978) Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. J Immunol, 121 (1): 315-320. PMID: 670704;10.4049/jimmunol.121.1.315
  32. 32. Bokeriia LA, Frolova MA, Kostava VT (1979) [Suppression of humoral antibody synthesis on exposure to hyperbaric oxygenation] [Article in Russian, English abstract]. Biull Eksp Biol Med, 87 (4): 320-322. PMID: 571294;10.1007/BF00804411
  33. 33. Bean JW, Smith CW (1952) Hypophyseal and adrenocortical factors in pulmonary damage induced by oxygen at atmospheric pressure. Am J Physiol, 172: 169-174. PMID: 13030734;10.1152/ajplegacy.1952.172.1.169
  34. 34. Houlihan RT, WeinerRE, Zavodni J (1966) Adrenocortical response to stimulated high altitude and to oxygen at high pressures. Physiologist, 9: 206 [abstract];
  35. 35. Brenner I, Shephard RJ, Shek PN (1999) Immune function in hyperbaric environments, diving, and decompression. Undersea Hyperb Med, 26 27-39. PMID: 10353182;
  36. 36. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci, 14: 60-67. DOI: 10.1016/0166- 2236(91)90022-M;10.1016/0166-2236(91)90022-
  37. 37. Bredt DS, Snyder SH (1992) Nitric oxide, a novel neuronal messenger. Neuron, 8: 3-11. DOI: 10.1016/0896-6273(92)90104-L;10.1016/0896-6273(92)90104-
  38. 38. Inamoto Y, Okuno F, Saito K, Tanaka Y, Watanabe K, Morimoto I, Yamashita U, Eto S (1991) Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun, 179: 886-891. DOI: 10.1016/0006-291X(91)91901-N;10.1016/0006-291X(91)91901-
  39. 39. Mialon P, Barthelemy L (1993) Effect of hyperbaric oxygen on prostaglandin and thromboxane synthesis in the cortex and the striatum of rat brain. Mol Chem Neuropathol, 20: 181-189. DOI: 10.1007/BF02815371;10.1007/BF028153718297421
  40. 40. Yang ZJ, Bosco G, Montante A, Ou XI, Camporesi EM (2001) Hyperbaric O2 reduces intestinal ischemia-reperfusion-induced TNF-alpha production and lung neutrophil sequestration. Eur J Appl Physiol 85: 96-103. DOI: 10.1007/s004210100503;10.1007/s00421010050311820317
  41. 41. Şen H, Erbağ G, Ovali MA, Oztopuz RO, Uzun M (2016) Investigation of endocrine and immunological response in fat tissue to hyperbaric oxygen administration in rats. Cell Mol Biol (Noisy-le-grand), 62 (5): 15-19. PMID: 27188864
  42. 42. Yin W, Badr AE, Mychaskiw G, Zhang JH (2002) Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res, 926: 165-171. DOI: 10.1016/S0006-8993(01)03304-2;10.1016/S0006-8993(01)03304-2
  43. 43. de Vries JE (1995) Immunosuppressive and anti-inflammatory properties of IL-10. Ann Med, 27: 537-541. DOI: 10.3109/07853899509002465;
  44. 44. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW (1990) Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg, 160: 519-524. DOI: 10.1016/S0002-9610(05)81019-0;10.1016/S0002-9610(05)81019-0
  45. 45. Luongo C, Imperatore F, Cuzzocrea S, Filippelli A, Scafuro MA, Mangoni G, Portolano F, Rossi F (1998) Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med, 26: 1972-1976. DOI: 10.1097/00003246-199812000-00022;10.1097/00003246-199812000-00022
  46. 46. Xu X, Yi H, Kato M, Suzuki H, Kobayashi S, Takahashi H, Nakashima I (1997) Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations of normal and autoimmune mice. Immunol Lett, 59: 79-84. DOI: 10.1016/S0165-2478(97)00104-1;10.1016/S0165-2478(97)00104-1
  47. 47. Takeshima F, Makiyama K, Doi T (1999) Hyperbaric oxygen as adjunct therapy for Crohn’s intractable enteric ulcer. Am J Gastroenterol, 94: 3374-3375. DOI: 10.1111/j.1572-0241.1999.03374.x;10.1111/j.1572-0241.1999.03374.x
  48. 48. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J (2001) Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol, 33: 337-339. DOI: 10.1097/00004836-200110000-00018;10.1097/00004836-200110000-00018
  49. 49. Freeman BA, Crapo JD (1981) Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem, 256: 10986-10992. PMID: 7287745;10.1016/S0021-9258(19)68544-3
  50. 50. Jamieson D, Chance B, Cadenas E, Boveris A (1986) The relation of free radical production to hyperoxia. Annu Rev Physiol, 48: 703-719. DOI: 10.1146/annurev.ph.48.030186.003415;10.1146/annurev.ph.48.030186.003415
  51. 51. Jamieson D (1991) Lipid peroxidation in brain and lungs from mice exposed to hyperoxia. Biochem Pharmacol, 41: 749-756. DOI: 10.1016/0006-2952(91)90076-H;10.1016/0006-2952(91)90076-
  52. 52. Dennog C, Radermacher P, Barnett YA, Speita G (1999) Antioxidant status in humans after exposure to hyperbaric oxygen. Mutation Res, 428: 83-89. DOI: 10.1016/S1383-5742(99)00034-4; 10.1016/S1383-5742(99)00034-4
  53. 53. Thom SR (2009) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol, 106: 988-995. DOI: 10.1152/japplphysiol.91004.2008;10.1152/japplphysiol.91004.2008266025218845776
  54. 54. George-Chandy A, Nordstrom I, Nygren E, Jonsson IM, Postigo J, Collins LV, Eriksson K (2008) Th17 development and autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol, 38: 1118-1126. DOI: 10.1002/eji.200737348;10.1002/eji.20073734818383034
  55. 55. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Bergd JM, Ottenhoff THM, Kuijpers TW, Holmdahle R, van Kootena C, Geldermana KA (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci USA, 107: 17686-17691. DOI:10.1073/pnas.1012016107/-/DCSupplemental;10.1073/pnas.1012016107/-/DCSupplemental
  56. 56. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W, Zeller K, Shimoda L, Topalian SL, Semenza GL, Dang CV, Pardoll DM, Pan F (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell, 146: 772-784. DOI: 10.1016/j.cell.2011.07.033;10.1016/j.cell.2011.07.033338767821871655
  57. 57. Munn DH, Mellor AL (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol, 34: 137-143. DOI: 10.1016/j.it.2012.10.001;10.1016/j.it.2012.10.001359463223103127
  58. 58. Lee K, Won HY, Bae MA, Hong JH, Hwang ES (2011) Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci USA, 108: 9548-9553. DOI: 10.1073/pnas.1012645108;10.1073/pnas.1012645108311132821593419
  59. 59. Won HY, Jang EJ, Lee K, Oh S, Kim HK, Woo HA, Kang SW, Yu DY, Rhee SG, Hwang ES (2013) Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells. J Immunol, 191: 4029-4037. DOI: 10.4049/jimmunol.1203247;10.4049/jimmunol.120324724048895
  60. 60. Olszański R, Konarski M, Kłos R, Siermontowski P (1999) [Oxygen exposures and diver's safety] [Article in Polish]. Lek Wojsk, 75 (1-2): 71-77. ISSN: 0024-0745;
  61. 61. Kleen M, Messmer K (1999) Toxicity of high PaO2. Minerva Anestesiol, 65: 393-396. PMID: 10394808; 62. Torbati D, Church DF, Keller JM, Pryor WA (1992) Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. Free Radic Biol Med, 13: 101-106. DOI: 10.1016/0891-5849(92)90070-W;
  62. 63. Thom SR, Bhopale V, Fisher D, Manevich Y, Huang PL, Buerk DG (2002) Stimulation of nitric oxide synthase in cerebral cortex due to elevated partial pressures of oxygen: an oxidative stress response. J Neurobiol, 51: 85-100. DOI: 10.1002/neu.10044;10.1002/neu.1004411932951
  63. 64. Harabin AL, Braisted JC, Flynn ET (1990) Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. J Appl Physiol, 69: 328-635. PMID: 2394655;10.1152/jappl.1990.69.1.3282394655
  64. 65. Narkowicz CH, Vial JH, McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun, 19: 71-80. DOI: 10.3109/10715769309056501;10.3109/107157693090565018225040
  65. 66. Dennog C, Hartmann A, Frey G, Speit G (1996) Detection of DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis, 11: 605-609. DOI: 10.1093/mutage/11.6.605.10.1093/mutage/11.6.6058962431
DOI: https://doi.org/10.1515/phr-2017-0012 | Journal eISSN: 2084-0535 | Journal ISSN: 1734-7009
Language: English
Page range: 13 - 18
Submitted on: Dec 13, 2011
Accepted on: May 7, 2017
Published on: Nov 30, 2017
Published by: Polish Hyperbaric Medicine and Technology Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Romuald Olszański, Maciej Konarski, Piotr Siermontowski, published by Polish Hyperbaric Medicine and Technology Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.